TY - JOUR
T1 - A high scale SARS-CoV-2 profiling by its whole-genome sequencing using Oxford Nanopore Technology in Kazakhstan
AU - Kairov, Ulykbek
AU - Amanzhanova, Amina
AU - Karabayev, Daniyar
AU - Rakhimova, Saule
AU - Aitkulova, Akbota
AU - Samatkyzy, Diana
AU - Kalendar, Ruslan
AU - Kozhamkulov, Ulan
AU - Molkenov, Askhat
AU - Gabdulkayum, Aidana
AU - Sarbassov, Dos
AU - Akilzhanova, Ainur
N1 - Copyright © 2022 Kairov, Amanzhanova, Karabayev, Rakhimova, Aitkulova, Samatkyzy, Kalendar, Kozhamkulov, Molkenov, Gabdulkayum, Sarbassov and Akilzhanova.
PY - 2022
Y1 - 2022
N2 - Severe acute respiratory syndrome (SARS-CoV-2) is responsible for the worldwide pandemic, COVID-19. The original viral whole-genome was sequenced by a high-throughput sequencing approach from the samples obtained from Wuhan, China. Real-time gene sequencing is the main parameter to manage viral outbreaks because it expands our understanding of virus proliferation, spread, and evolution. Whole-genome sequencing is critical for SARS-CoV-2 variant surveillance, the development of new vaccines and boosters, and the representation of epidemiological situations in the country. A significant increase in the number of COVID-19 cases confirmed in August 2021 in Kazakhstan facilitated a need to establish an effective and proficient system for further study of SARS-CoV-2 genetic variants and the development of future Kazakhstan's genomic surveillance program. The SARS-CoV-2 whole-genome was sequenced according to SARS-CoV-2 ARTIC protocol (EXP-MRT001) by Oxford Nanopore Technologies at the National Laboratory Astana, Kazakhstan to track viral variants circulating in the country. The 500 samples kindly provided by the Republican Diagnostic Center (UMC-NU) and private laboratory KDL "Olymp" were collected from individuals in Nur-Sultan city diagnosed with COVID-19 from August 2021 to May 2022 using real-time reverse transcription-quantitative polymerase chain reaction (RT-qPCR). All samples had a cycle threshold (Ct) value below 20 with an average Ct value of 17.03. The overall average value of sequencing depth coverage for samples is 244X. 341 whole-genome sequences that passed quality control were deposited in the Global initiative on sharing all influenza data (GISAID). The BA.1.1 (
n = 189), BA.1 (
n = 15), BA.2 (
n = 3), BA.1.15 (
n = 1), BA.1.17.2 (
n = 1) omicron lineages, AY.122 (
n = 119), B.1.617.2 (
n = 8), AY.111 (
n = 2), AY.126 (
n = 1), AY.4 (
n = 1) delta lineages, one sample B.1.1.7 (
n = 1) belongs to alpha lineage, and one sample B.1.637 (
n = 1) belongs to small sublineage were detected in this study. This is the first study of SARS-CoV-2 whole-genome sequencing by the ONT approach in Kazakhstan, which can be expanded for the investigation of other emerging viral or bacterial infections on the country level.
AB - Severe acute respiratory syndrome (SARS-CoV-2) is responsible for the worldwide pandemic, COVID-19. The original viral whole-genome was sequenced by a high-throughput sequencing approach from the samples obtained from Wuhan, China. Real-time gene sequencing is the main parameter to manage viral outbreaks because it expands our understanding of virus proliferation, spread, and evolution. Whole-genome sequencing is critical for SARS-CoV-2 variant surveillance, the development of new vaccines and boosters, and the representation of epidemiological situations in the country. A significant increase in the number of COVID-19 cases confirmed in August 2021 in Kazakhstan facilitated a need to establish an effective and proficient system for further study of SARS-CoV-2 genetic variants and the development of future Kazakhstan's genomic surveillance program. The SARS-CoV-2 whole-genome was sequenced according to SARS-CoV-2 ARTIC protocol (EXP-MRT001) by Oxford Nanopore Technologies at the National Laboratory Astana, Kazakhstan to track viral variants circulating in the country. The 500 samples kindly provided by the Republican Diagnostic Center (UMC-NU) and private laboratory KDL "Olymp" were collected from individuals in Nur-Sultan city diagnosed with COVID-19 from August 2021 to May 2022 using real-time reverse transcription-quantitative polymerase chain reaction (RT-qPCR). All samples had a cycle threshold (Ct) value below 20 with an average Ct value of 17.03. The overall average value of sequencing depth coverage for samples is 244X. 341 whole-genome sequences that passed quality control were deposited in the Global initiative on sharing all influenza data (GISAID). The BA.1.1 (
n = 189), BA.1 (
n = 15), BA.2 (
n = 3), BA.1.15 (
n = 1), BA.1.17.2 (
n = 1) omicron lineages, AY.122 (
n = 119), B.1.617.2 (
n = 8), AY.111 (
n = 2), AY.126 (
n = 1), AY.4 (
n = 1) delta lineages, one sample B.1.1.7 (
n = 1) belongs to alpha lineage, and one sample B.1.637 (
n = 1) belongs to small sublineage were detected in this study. This is the first study of SARS-CoV-2 whole-genome sequencing by the ONT approach in Kazakhstan, which can be expanded for the investigation of other emerging viral or bacterial infections on the country level.
U2 - 10.3389/fgene.2022.906318
DO - 10.3389/fgene.2022.906318
M3 - Article
C2 - 36118859
SN - 1664-8021
VL - 13
SP - 906318
JO - Frontiers in Genetics
JF - Frontiers in Genetics
ER -